GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Hologic, Inc. (HOLX) [hlAlert]

Rating:
Buy HOLX
down 15.42 %

Hologic, Inc. (HOLX) upgraded to Buy with price target $20 by Needham

Posted on: Wednesday,  Nov 12, 2008  9:25 AM ET by Needham

Needham rated Buy Hologic, Inc. (NASDAQ: HOLX) on 11/12/2008, when the stock price was $12.84. Since then, Hologic, Inc.
has lost 15.42% of its value until Needham rated HOLX Hold on 01/09/2009, when the price was $10.86.
If you would have followed this Needham's recommendation on HOLX, you would have lost 15.42% of your investment in 58 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2016 8:25 AM Buy
None
33.50 41.00
as of 12/24/2008
1 Week up  4.51 %
1 Month up  15.47 %
3 Months up  14.77 %
1 YTD up  14.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/5/2015 8:25 AM Hold
None
31.60
6/25/2014 12:00 AM Buy
None
25.60 30.00
10/2/2013 8:25 AM Buy
None
20.98 26.00
12/5/2011 8:25 AM Buy
None
17.48 22.00
1/9/2009 9:25 AM Hold
None
10.86
11/12/2008 9:25 AM Buy
None
12.84 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy